Neurology Masterclass (18 CPD points)
- 21st to 23rd September 2019, New Delhi, India
- 25th to 27th September 2019, Mumbai, India
Provided in collaboration with SHARD Life Sciences
About the Event
Up to date practical information on how to manage medicines in common specialised medical conditions including Parkinson’s Disease, falls and fragility fractures, diabetes, psychiatric disease, stroke as well as expand on the concepts of medicines rationalisation and deprescribing.
A chance to review the clinical benefits of particular medications in specific populations.
An opportunity to share and exchange views and experiences with our expert faculty speakers
Dementia diagnosis and subtyping – pitfalls and pearls.
Rational investigations – neuropsychology and neuroimaging
Diagnosing and managing neuropsychiatric symptoms
Medications : stopping, starting and the future.
Parkinsonism and tremor
Hyperkinetic movement disorders
Movement disorders cases
Pathology and aetiology of Multiple Sclerosis including recent global trends in epidemiology.
Clinical presentation and diagnosis of Multiple Sclerosis including the revised Mc Donald Criteria (with cases)
Disease modifying therapies for multiple sclerosis including treating to target and infectious co morbidities (with cases)
Symptomatic treatments for multiple sclerosis (with cases)
Stroke and general neurology
Cerebrovascular structure and anatomy
Perfusion and ischaemia at a molecular level
Hyperacute stroke assessment
Thrombolysis and Thrombectomy
Secondary prevention of stroke
Stroke and atrial fibrillation
Spasticity – assessment and management
Anatomy of the lower motor neuron pathway
Peripheral neuropathy – recognising and diagnosing Break
Motor neurone disease
Recognising and managing neuromuscular junction disorders - Myasthenia Gravis
Infections of the central nervous system
Professor Arshad Majid’s professional mission is to develop new therapies for patients afflicted with neurological diseases, especially cerebrovascular diseases.
Professor Majid’s training and background is unique in that as well as being a leading translational neuroscientist, he is also an accomplished Vascular and Interventional Neurologist. He graduated in Medicine from the University of Glasgow, Scotland. After obtaining Membership of the Royal College of Physicians (MRCP) he moved to the USA where he did further training in Neurology at the University of Pennsylvania and Fellowship training in Stroke Research at Washington University in St. Louis. He did additional Fellowship training in Endovascular Surgical Neuroradiology at the Medical College of Wisconsin. Professor Majid has published extensively in high impact international peer-reviewed journals, and presented at national and international meetings. After finishing his training, Professor Majid served as the founding Director of the Division of Cerebrovascular Diseases at Michigan State University and was the founding Medical Director of the William and Claire Dart Stroke Center at Sparrow Health System.
Professor Majid is a diplomate of the American Board of Psychiatry and Neurology and is a Fellow of the Royal College of Physicians and Surgeons of Glasgow and also serves as their Regional Advisor.
He joined the University of Sheffield and Royal Hallamshire Hospital in August 2013 as Professor of Cerebrovascular Neurology and Consultant Neurologist.
Professor Majid also serves as a Governor of Rotherham NHS Foundation Trust.
Dr Ali is a consultant in Stroke, Geriatrics and General Internal Medicine and departmental research lead at Sheffield Teaching Hospitals NHS Foundation Trust, UK. He is also an Honorary Senior Clinical Lecturer at the University of Sheffield, UK. He graduated from Manchester, UK in 2004, and spent most of his post graduate training in the north of England.
He has supervised numerous postgraduate masters students and currently supervises a PhD student and academic clinical fellow in neurosciences. His main research interests include health economics, cerebrovascular physiology, effects of aerobic exercise after stroke, and rehabilitation devices in stroke and geriatrics.
Dr Hewamadduma graduated from University of Colombo with distinctions and completed his house officer training at the prestigious professorial medical and surgical departments at the national hospital of Sri Lanka (NHSL). He completed post intern training at the department of neurology in NHSL. Having received the Commonwealth scholarship for his performance at medical school he continued his training in the UK. Channa is a fellow at Royal college of physicians London and Edinburgh. He was awarded a competitive MRC Clinical training fellowship to complete a PhD in neurogenetics of ALS at the international centre for MND in Sheffield (SiTRAN). He completed neurology specialist training and obtained CCST in neurology. He also undertook training fellowship in Newcastle highly specialised services for muscle diseases (John Walton centre).
Currently Channa is a neuromuscular specialist neurologist at Sheffield Teaching Hospitals Foundation Trust (STHFT) and is the co chair of the South Yorkshire and Humber regional neuromuscular network. He also has a sub specialist interest in neurological Sleep Disorders and shares a regional sleep clinic. HIs research interests are MND, Neurogenetics, Hereditary spastic paraparesis, ataxia, Duchenne muscular dystrophy, myasthenia gravis and neuropathy (small fiber neuropathy). He is active in both clinical and basic science research. Channa has number of publications in high impact factor journals. In addition Channa is the audit lead to the department of neurology and has pioneered the use of structured judgment of mortality cases to learn lessons from deaths to improve care and safety of patients.
Dr Paling is a consultant neurologist at the Royal Hallamshire Hospital in Sheffield. His neurological training was in Queen Square, London where he obtained a PhD in MS research with Raj Kappoor and David Miller, Manchester and Sydney. His clinical interests are in multiple sclerosis, and he is particularly interested in trials of MS and is a principle investigator for trials of new disease modifying therapies in MS. Other interests include medical education where he is strategic director for the UK MS Academy, and in service development. He is the clinical lead of the Multiple Sclerosis Centre Sheffield.
100% of the value of purchase can be refunded if requested at least 4 weeks prior to the course date.
50% of the value of purchase can be refunded if requested between 2 to 4 weeks prior to the course date.
No refund can be offered if requests are made less than 2 weeks to course dates.